Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer

Two histone methyltransferases, enhancer of zeste homolog 2 (EZH2) and nuclear SET domain-containing 2 (NSD2), are aberrantly expressed in several types of human cancers. However, the regulatory relationship between EZH2 and NSD2 and their prognostic values in breast cancer (BC) have not been fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Bo, Liu, Xiumin, Li, Zhengjin, Zhao, Lixian, Pan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921704/
https://www.ncbi.nlm.nih.gov/pubmed/33665162
http://dx.doi.org/10.3389/fonc.2020.600514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921704/
https://www.ncbi.nlm.nih.gov/pubmed/33665162
http://dx.doi.org/10.3389/fonc.2020.600514

Ejemplares similares